Back to search results

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-cell Lymphoma Refractory · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed B-cell Non-Hodgkin Lymphoma · Refractory High Grade B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hopital Henri Mondor, Créteil, France

    Contact: Study coordinator (François LEMONNIER) · francois.lemonnier@aphp.fr
    Contact: Principal Investigator (François LEMONNIER, Doctor)

  • Chu Dijon Bourgogne, Dijon, France

    Contact: Study coordinator (Amandine DURAND) · amandine.durand@chu-dijon.fr
    Contact: Principal Investigator (Amandine DURAND, Doctor)

  • Chu de Grenoble, La Tronche, France

    Contact: Study coordinator (Sylvain CARRAS) · scarras@chu-grenoble.fr
    Contact: Principal Investigator (Sylvain CARRAS, Doctor)

  • Chru de Lille, Lille, France

    Contact: Study coordinator (Franck MORSCHHAUSER) · franck.morschhauser@chu-lille.fr
    Contact: Principal Investigator (Franck MORSCHHAUSER, Professor)

  • Institut Paoli Calmettes, Marseille, France

    Contact: Study coordinator (Gabriel BRISOU) · brisoug@ipc.unicancer.fr
    Contact: Principal Investigator (Gabriel BRISOU, Doctor)

  • Chu de Montpellier, Montpellier, France

    Contact: Study coordinator (Charles HERBAUX) · c-herbaux@chu-montpellier.fr
    Contact: Principal Investigator (Charles HERBAUX, Doctor)

  • Chu de Nantes, Nantes, France

    Contact: Study coordinator (Benoit TESSOULIN) · benoit.tessoulin@chu-nantes.fr
    Contact: Principal Investigator (Benoit TESSOULIN, Doctor)

  • Hopital Saint-Louis, Paris, France

    Contact: Study coordinator (Catherine THIEBLEMONT) · catherine.thieblemont@aphp.fr
    Contact: Principal Investigator (Catherine THIEBLEMONT, Professor)

  • Chu de Bordeaux, Pessac, France

    Contact: Study coordinator (François-Xavier GROS) · francois-xavier.gros@chu-bordeaux.fr
    Contact: Principal Investigator (François-Xavier GROS, Doctor)

  • Chu Pontchaillou, Rennes, France

    Contact: Study coordinator (Roch HOUOT) · roch.houot@chu-rennes.fr
    Contact: Principal Investigator (Roch HOUOT, Professor)

  • Centre Henri Becquerel, Rouen, France

    Contact: Study coordinator (Fabrice JARDIN) · fabrice.jardin@chb.unicancer.fr
    Contact: Principal Investigator (Fabrice JARDIN, Professor)

  • Iuct Oncopole, Toulouse, France

    Contact: Study coordinator (Lucie OBERIC) · oberic.lucie@iuct-oncopole.fr
    Contact: Principal Investigator (Lucie OBERIC, Doctor)

  • Chu Brabois, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Arnaud CAMPIDELLI) · A.CAMPIDELLI@chru-nancy.fr
    Contact: Principal Investigator (Arnaud CAMPIDELLI, Doctor)
Study leads

  • Catherine THIEBLEMONT, Prof. Dr.

    Principal Investigator

    Hôpital Saint-Louis

  • Gabriel BRISOU, Prof. Dr.

    Principal Investigator

    Institut Paoli-Calmettes

  • François-Xavier GROS, Prof. Dr.

    Principal Investigator

    University Hospital, Bordeaux

View source on ClinicalTrials.gov(opens in a new tab)